Saturday, December 09, 2006

Pfizer wins Canadian ruling on Lipitor

It looks like Pfizer has blocked an attempt by Novopharm to sell a generic Lipitor. There is one mistake in this article -- Novopharm is not "closely held" as stated but in fact is owned by Israel-based Teva, which is a publicly traded company.

From Crain's New York Business:
Pfizer Inc. said Friday that a Canadian federal court has blocked Novopharm Ltd. from launching a generic version of its blockbuster cholesterol drug Lipitor until the patent expires.

The ruling, by the Canadian Federal Court in Toronto, prevents closely held Novopharm from selling a generic form of Lipitor until its Canadian patent ends in July 2010. The ruling is subject to appeal, said Pfizer, which sued to block Toronto-based Novopharm from moving forward with its generic plans. ...more

No comments: